Unichem Laboratories (NSE:UNICHEMLAB) Marketable Securities: ₹96 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:UNICHEMLAB Unichem Laboratories Ltd NSE:UNICHEMLAB
78 GF Score
Price ₹638.75
GF Value ₹692.37
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Unichem Laboratories Marketable Securities?

Unichem Laboratories NSE:UNICHEMLAB -1.82% 78 Marketable Securities is ₹96 Mil as of Mar. 2026. GuruFocus rates NSE:UNICHEMLAB with a GF Score™ of 78/100 and a GF Value™ of ₹692.37 (Fairly Valued). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Unichem Laboratories's Marketable Securities for the quarter that ended in Mar. 2026 was ₹96 Mil.

Unichem Laboratories's annual Marketable Securities declined from Mar. 2024 (₹13 Mil) to Mar. 2025 (₹0 Mil) but then increased from Mar. 2025 (₹0 Mil) to Mar. 2026 (₹96 Mil).

Unichem Laboratories  (NSE:UNICHEMLAB) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Unichem Laboratories Marketable Securities Related Terms

Unichem Laboratories Marketable Securities Historical Data

* Premium members only.

The historical data trend for Unichem Laboratories's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unichem Laboratories Marketable Securities Chart

Unichem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,635.80 15.36 13.40 0.00 96.40

Unichem Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 157.10 0.00 96.40
NSE:UNICHEMLAB
78GF Score
Unichem Laboratories Ltd NSE:UNICHEMLAB
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unichem Laboratories Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹96 Mil mean?
Unichem Laboratories (NSE:UNICHEMLAB) has a Marketable Securities of ₹96 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Unichem Laboratories and its competitors.
Is Unichem Laboratories' Marketable Securities too high?
Unichem Laboratories' current Marketable Securities is ₹96 Mil. Overall, Unichem Laboratories has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Unichem Laboratories' Marketable Securities compare to ZTS and UTHR?
Unichem Laboratories' Marketable Securities of ₹96 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Unichem Laboratories and its competitors. Unichem Laboratories's current Marketable Securities is ₹96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unichem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Unichem Laboratories (NSE:UNICHEMLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹692.37, compared to a current price of ₹638.75 — trading 7.7% below its estimated fair value. The current Marketable Securities is ₹96 Mil. Unichem Laboratories' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Unichem Laboratories (NSE:UNICHEMLAB), the current Marketable Securities is ₹96 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued. The current stock price of ₹638.75 is trading 7.7% below its estimated GF Value™ of ₹692.37. GuruFocus considers Unichem Laboratories to be Fairly Valued.

Key valuation signals for NSE:UNICHEMLAB:

  • Marketable Securities: ₹96 Mil
  • GF Value™: ₹692.37 vs. price of ₹638.75 (7.7% below fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unichem Laboratories Business Description

Other Exchanges 506690:India
Address Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
78GF Score

Get the complete analysis for NSE:UNICHEMLAB

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹638.75
Price
₹692.37
GF Value